广州洁特生物过滤股份有限公司 关于对参股公司计提资产减值准备的公告

Core Viewpoint - The company announced a provision for asset impairment related to its investment in Guangzhou Lanbo Biological Technology Co., Ltd. due to poor financial performance and expected inability to recover the full investment amount [2][4]. Group 1: Company Overview - Guangzhou Jiete Biological Filtration Co., Ltd. holds a 15.0007% stake in Guangzhou Lanbo Biological Technology Co., Ltd., which specializes in the manufacturing of laboratory analytical instruments [1][2]. - Lanbo Biological's business scope includes manufacturing laboratory analytical instruments, wholesale and retail trade of goods, and various technology research and development services [2]. Group 2: Asset Impairment Provision - The company has recognized an asset impairment provision of 26,301,158.21 yuan, which is expected to reduce the company's net profit for the year 2025 by the same amount [4][11]. - The decision to provision for impairment was based on Lanbo Biological's net loss of 3,768,635.52 yuan for the year 2025, indicating significant impairment signs [2][11]. Group 3: Financial Performance - For the year 2025, the company reported a total revenue of 56,536.29 million yuan, reflecting a year-on-year growth of 1.20% [10]. - The company's total profit decreased by 36.97% to 6,026.55 million yuan, and the net profit attributable to the parent company fell by 36.26% to 4,821.28 million yuan [10][11].